In glioblastoma, for instance, IL-6 has been reported to induce NFκB, resulting in STAT3 activation and greater tumor aggressiveness [75], while inhibition of IL-6/STAT3 and NFκB decreases glioma growth [76], and these results support an impact of inflammation on brain tumor development. Here, IL6 is linked to glioblastoma.